Not Signed In -
Albumin |
Albuminar-5; Albunex; Alubutein; Buminate; Plasbumin |
Albumin can refer to albumins, a group of proteins ovalbumin, a protein in egg white serum albumin, a ubiquitous protein in blood human serum albumin bovine serum albumin (cattle serum albumin) or BSA, often used in medical and molecular biology labs See also albumen (egg white) This is a disambiguation page: a list of articles associated with the same title. If an internal link referred you to this page, you may wish to change the link to point directly to the intended article. ...
Wikipedia - [full article]
Albumin Clinical Trials
- Formation and Severity of Pressure Ulcers Associated With 4% Albumin Vs. 0.9% Sodium Chloride
ClinicalTrials.gov Identifier: NCT00228657 - Active, not recruiting
Pressure Ulcer, Area; Pressure Ulcer, Grade; Albumin Level; Risk Score; Length of ICU Stay
- Albumin Administration in Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
ClinicalTrials.gov Identifier: NCT00124228 - Recruiting
Cirrhosis
- Vasoconstrictors as Alternatives to Albumin after LVP (Large-Volume Paracentesis) in Cirrhosis
ClinicalTrials.gov Identifier: NCT00108355 - Recruiting
Cirrhosis; Ascites
- Albumin in Acute Ischemic Stroke (ALIAS) Trial
ClinicalTrials.gov Identifier: NCT00235495 - Recruiting
Acute Ischemic Stroke
- High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury.
ClinicalTrials.gov Identifier: NCT00152685 - Recruiting
severe head injury
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00307255 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00520000 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure
ClinicalTrials.gov Identifier: NCT00224705 - Recruiting
Hepatitis
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00436709 - Active, not recruiting
Breast Cancer
- Therapy with Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients with Breast Cancer
ClinicalTrials.gov Identifier: NCT00110695 - Active, not recruiting
Breast Neoplasms
- Acute Hemodynamics of Albumin vs Normal Saline in Cirrhosis
ClinicalTrials.gov Identifier: NCT00511394 - Recruiting
Cirrhosis; Ascites
- Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction
ClinicalTrials.gov Identifier: NCT00428506 - Recruiting
Tense Ascites in Cirrhosis
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Bevacizumab, and Gemcitabine as First-Line Therapy in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00503906 - Recruiting
Breast Cancer
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00521313 - Recruiting
Lung Cancer
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Carboplatin, and Radiation Therapy in Treating Patients With Stage III Non-Small-Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00544648 - Recruiting
Lung Cancer
- Safety, Tolerability, and Immunogenicity of an Investigational Vaccine with Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age
ClinicalTrials.gov Identifier: NCT00092404 - Active, not recruiting
Measles; Mumps; Rubella; Varicella
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00499291 - Not yet recruiting
Cancer
- Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
ClinicalTrials.gov Identifier: NCT00397761 - Recruiting
Breast Cancer
- Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
ClinicalTrials.gov Identifier: NCT00319839 - Recruiting
Head and Neck Cancer
- Treatment of Subarachnoid Hemorrhage With Human Albumin
ClinicalTrials.gov Identifier: NCT00283400 - Recruiting
Subarachnoid Hemorrhage
- Early Albumin Resuscitation During Septic Shock
ClinicalTrials.gov Identifier: NCT00327704 - Recruiting
Septic Shock
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or Other Solid Tumors
ClinicalTrials.gov Identifier: NCT00470548 - Recruiting
Breast Cancer; Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
ClinicalTrials.gov Identifier: NCT00287664 - Suspended
Cirrhosis; Hepatorenal Syndrome
- Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00005821 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- GM-CSF and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
ClinicalTrials.gov Identifier: NCT00466960 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00499252 - Recruiting
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00553462 - Not yet recruiting
Lung Cancer
- Elimination of Albumin-Bound Substances by MARS and Prometheus
ClinicalTrials.gov Identifier: NCT00407004 - Completed
Liver Failure
- A Pilot Study to Evaluate the Effects of Nateglinide Vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
ClinicalTrials.gov Identifier: NCT00238472 - Completed
Diabetes Mellitus, Type 2
- Suc-HSA for HIV-1 Infection
ClinicalTrials.gov Identifier: NCT00128063 - Completed
HIV-1
- The Utility of Ischemia Modified Albumin (IMA) in Sepsis
ClinicalTrials.gov Identifier: NCT00448968 - Completed
Sepsis; Severe Sepsis; Systemic Inflammatory Response Syndrome; Sepsis Syndrome
- Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function
ClinicalTrials.gov Identifier: NCT00442299 - Suspended
Chronic Kidney Disease
- The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
ClinicalTrials.gov Identifier: NCT00240045 - Completed
Type 2 Hepatorenal Syndrome; Refractory Ascites
- An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients with End-Stage Renal Disease Who are Highly Sensitized to Transplant Antigens
ClinicalTrials.gov Identifier: NCT00000935 - Completed
End-Stage Renal Disease; Kidney Transplantation
- The Ischemia Modified Albumin In Diagnosing Ischemic New Events
ClinicalTrials.gov Identifier: NCT00355992 - Suspended
Heart Disease, Ischemic; Ischemia, Myocardial; Ischemic Heart Disease; Unstable Angina
email this page
print this page
bookmark this page
feedback on this page
